Telomir Pharmaceuticals, Inc. (TELO)
0.88
+0.10
(+12.81%)
USD |
NASDAQ |
Nov 06, 10:07
Telomir Pharmaceuticals Price to Book Value : 12.02 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 10.66 |
| November 04, 2026 | 11.96 |
| November 03, 2026 | 12.43 |
| November 02, 2026 | 12.50 |
| October 30, 2026 | 12.78 |
| October 29, 2026 | 13.17 |
| October 28, 2026 | 13.80 |
| October 27, 2026 | 13.94 |
| October 26, 2026 | 13.64 |
| October 23, 2026 | 13.32 |
| October 22, 2026 | 13.80 |
| October 21, 2026 | 13.94 |
| October 20, 2026 | 13.80 |
| October 19, 2026 | 14.21 |
| October 16, 2026 | 14.35 |
| October 15, 2026 | 14.35 |
| October 14, 2026 | 14.35 |
| October 13, 2026 | 14.89 |
| October 12, 2026 | 15.03 |
| October 09, 2026 | 15.30 |
| October 08, 2026 | 15.71 |
| October 07, 2026 | 15.30 |
| October 06, 2026 | 16.40 |
| October 05, 2026 | 16.53 |
| October 02, 2026 | 16.12 |
| Date | Value |
|---|---|
| October 01, 2026 | 15.99 |
| September 30, 2026 | 16.40 |
| September 29, 2026 | 15.99 |
| September 28, 2026 | 16.40 |
| September 25, 2026 | 16.81 |
| September 24, 2026 | 16.53 |
| September 23, 2026 | 16.67 |
| September 22, 2026 | 17.08 |
| September 21, 2026 | 16.94 |
| September 18, 2026 | 16.81 |
| September 17, 2026 | 15.30 |
| September 16, 2026 | 15.44 |
| September 15, 2026 | 15.99 |
| September 14, 2026 | 15.99 |
| September 11, 2026 | 15.99 |
| September 10, 2026 | 16.12 |
| September 09, 2026 | 16.67 |
| September 08, 2026 | 16.26 |
| September 04, 2026 | 15.85 |
| September 03, 2026 | 15.85 |
| September 02, 2026 | 15.30 |
| September 01, 2026 | 15.03 |
| August 31, 2026 | 15.30 |
| August 28, 2026 | 15.58 |
| August 27, 2026 | 16.26 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 9.721 |
| Veru, Inc. | 1.244 |
| Johnson & Johnson | 8.023 |
| Eli Lilly & Co. | 32.06 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0143 |
| Price | 0.88 |
| Earnings Yield | -103.3% |
| Market Cap | 60.52M |
| PEGY Ratio | -0.0143 |